Professor Robert Leonard is a Professor of Medical Oncology based at Imperial College, London.

Prof Leonard originally trained and qualified at Charing Cross Hospital, where he was awarded the Clinical Gold Medal and six of the final year prizes. He Undertook Post-graduate research Fellowships at Oxford’s Radcliffe Infirmary and Harvard Medical School and later went to to become Professor of Medical Oncology at Swansea Medical School and Director of the South West Wales Cancer Institute. His current roles include Professor of Cancer Studies and Chief of Service for Medical Oncology at Imperial College, London.

Robert is a medical oncologist with a major interest in the management of breast cancer. He is a co-founder and Medical Director for  Maggies’ Cancer Caring Centres UK, and has chaired the professional advisory board. Since 2009 he has been Chair of the Scientific Board for  Breast Cancer Care UK. He set up and Chairs the  International Anglo Celtic Collaborative Oncology Trials Group. He is author/co-author of more than 350 peer reviewed original papers and reviews. He has been a senior advisor to Cancer Research UK and is lead investigator several previous and current UK clinical Trials. He also regularly acts as expert oncology witness for legal cases.

Professor Leonard is multi-lingual speaking English, French and Spanish.

Professor Hani Gabra is a Professor of Medical Oncology based at Imperial College London.

Professor Gabra studied Medicine at the University of Glasgow. He graduated with a BSc (Hons) in Molecular Biology and MB ChB in 1987. He went on to complete his specialist training in Cancer Medicine in Edinburgh and then on to the Imperial College London.

His clinical work is conducted at the Hammersmith Hospital and the Queen Charlotte Hospital for Women. He runs a large evidence based/research led clinical practice providing medical oncology services for women with gynaecological cancer, embedded within a comprehensive large multidisciplinary team. He also provides a clinical trials service encompassing all phases of clinical research, and has interests in upper gastrointestinal cancer and adenocarcinoma of unknown primary.

Professor Gabra is also Chief of Service of the West London Gynaecological Cancer Centre based at Queen Charlotte's/Hammersmith Hospital and is also head of the Section of Molecular Therapeutics in the Department of Oncology at Imperial College and Director of the Ovarian Cancer Action (HHMT) Research Unit, a core funded research unit based at Imperial College London. In addition he also has an additional role as Strategic Theme Leader for Cancer Research at Imperial College.